{{Rsnum
|rsid=1860190
|Chromosome=17
|position=34249554
|Orientation=minus
|GMAF=0.4513
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 39.8 | 49.6 | 10.6
| HCB | 14.6 | 45.3 | 40.1
| JPT | 8.8 | 52.2 | 38.9
| YRI | 5.4 | 35.4 | 59.2
| ASW | 15.8 | 47.4 | 36.8
| CHB | 14.6 | 45.3 | 40.1
| CHD | 22.9 | 44.0 | 33.0
| GIH | 33.7 | 50.5 | 15.8
| LWK | 5.5 | 50.9 | 43.6
| MEX | 20.7 | 48.3 | 31.0
| MKK | 12.8 | 48.7 | 38.5
| TSI | 39.2 | 50.0 | 10.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=22117412
|Title=[Association of polymorphic markers of CCL2 gene with essential hypertension]
}}
{{PMID Auto
|PMID=22258388
|Title=Association of NOS2 and potential effect of VEGF, IL6, CCL2 and IL1RN polymorphisms and haplotypes on susceptibility to GCA--a simultaneous study of 130 potentially functional SNPs in 14 candidate genes
}}

{{on chip | Affy GenomeWide 6}}